Vaso (VASO) Stock Price, News & Analysis

Company Overview

Vaso Corporation, together with its subsidiaries, operates in the healthcare equipment and information technology industries in the United States and internationally. The company operates through three segments: IT, Professional Sales Service, and Equipment. The IT segment primarily focuses on healthcare IT and managed network technology services. This segment offers managed diagnostic imaging applications, managed network infrastructure, managed network transport, and managed network security services. The Professional Sales Service segment principally focuses on the sale of healthcare capital equipment for General Electric Healthcare (GEHC) into the health provider middle market. Its offerings include GEHC diagnostic imaging equipment and ultrasound systems, GEHC service agreements, GEHC training, and GEHC and third-party financial services. The Equipment segment primarily focuses on the design, manufacture, sale, and service of proprietary medical devices and software. This segment offers Biox series Holter monitors and ambulatory blood pressure recorders; ARCS series analysis, reporting, and communication software for ECG and blood pressure signals, including cloud-based software and algorithm subscription services; MobiCare multi-parameter wireless vital-sign monitoring systems; and Enhanced External Counterpulsation therapy systems for non-invasive and outpatient treatment of ischemic heart disease. The company was formerly known as Vasomedical, Inc. and changed its name to Vaso Corporation in November 2016. Vaso Corporation was incorporated in 1987 and is headquartered in Plainview, New York.

Key Stats

• Today's Range: $0.17 to $0.19
• 50-Day Range: $0.16 to $0.19
• 52-Week Range: $0.11 to $0.21
• Volume: 117,461 shs
• Average Volume: 130,447 shs
• Market Capitalization: $33.08 million
• P/E Ratio: 18.82
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

VASO Stock Analysis - Frequently Asked Questions

How have VASO shares performed this year?

Vaso's stock was trading at $0.1749 at the start of the year. Since then, VASO shares have increased by 7.5% and is now trading at $0.1880.

How were Vaso's earnings last quarter?

Vaso Corporation (OTCMKTS:VASO) released its quarterly earnings results on Tuesday, March, 31st. The company reported $0.01 EPS for the quarter. The company had revenue of $27.02 million for the quarter. Vaso had a net margin of 1.76% and a trailing twelve-month return on equity of 5.66%.

How do I buy shares of Vaso?

Shares of VASO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Vaso own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Vaso investors own include Aramark (ARMK), AutoZone (AZO), Bank of America (BAC), Bristol Myers Squibb (BMY), Cisco Systems (CSCO), Intel (INTC) and Kimco Realty (KIM).

Company Calendar

• Last Earnings: 3/31/2026
• Today: 5/05/2026
• Next Earnings (Estimated): 5/13/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Medical Equipment
• Current Symbol: OTCMKTS:VASO
• CIK: 839087
• Web: www.vasocorporation.com
• Phone: 516-997-4600
• Fax: 516-997-2299
• Employees: 260
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): $0.01
• Trailing P/E Ratio: 18.82
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $1.57 million
• Net Margins: 1.76%
• Pretax Margin: -1.47%
• Return on Equity: 5.66%
• Return on Assets: 1.88%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.59
• Quick Ratio: 1.57

Sales & Book Value

• Annual Sales: $89.10 million
• Price / Sales: 0.37
• Cash Flow: $0.04 per share
• Price / Cash Flow: 4.61
• Book Value: $0.17 per share
• Price / Book: 1.11

Miscellaneous

• Outstanding Shares: 175,950,000
• Free Float: 98,798,000
• Market Cap: $33.08 million
• Optionable: Not Optionable
• Beta: 0.53